DEF 14A Filing

Company

Calidi Biotherapeutics, Inc.

Filed

August 20, 2024

Period of Report

August 19, 2024

Accession Number

0001493152-24-033186

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →